Abstract
Cluster headache is a debilitating disorder. Oral prophylactic treatments may act with a significant delay, cause side effects, or fail to control the attacks. Injections targeting the occipital nerve have raised interest for the management of CH. Their efficacy is thought to result from the anatomical convergence of trigeminal and cervical afferents in the trigeminal nucleus caudalis. Efficacy and safety of occipital injections are now documented by 2 randomized controlled trials and several case series, though the optimal technique and substance to be injected are still subject to discussion due to varied approaches in the published studies. The evidence supports the use of injected steroids, with or without the addition of an anesthetic. Side effects of local pain are common, but unlikely to be severe. Systemic effects related to steroid absorption are reported but infrequent. Occipital injections provide a rapid benefit on the frequency of attacks and can be used as an adjunct to an oral prophylactic for a quicker improvement. Whether or not this approach can be used without any oral prophylaxis is still to be determined. The technique is easy to master, has a low cost, and should be learned by physicians involved in CH management.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Bogduk N. The clinical anatomy of the cervical dorsal rami. Spine. 1982;7:319–30.
Cruveilhier J. The anatomy of the human body. New York: Harper & Brothers; 1844.
Tubbs RS, Mortazavi MM, Loukas M, D’Antoni AV, Shoja MM, Cohen-Gadol AA. Cruveilhier plexus: an anatomical study and a potential cause of failed treatments for occipital neuralgia and muscular and facet denervation procedures. J Neurosurg. 2011;115:929–33. doi:10.3171/2011.5.JNS102058.
Vital JM, Grenier F, Dautheribes M, Baspeyre H, Lavignolle B, Senegas J. An anatomic and dynamic study of the greater occipital nerve (n. of Arnold). Applications to the treatment of Arnold’s neuralgia. Surg Radiol Anat. 1989;11:205–10.
Becser N, Bovim G, Sjaastad O. Extracranial nerves in the posterior part of the head. Anatomic variations and their possible clinical significance. Spine. 1998;23:1435–41.
Bovim G, Bonamico L, Fredriksen TA, Lindboe CF, Stolt-Nielsen A, Sjaastad O. Topographic variations in the peripheral course of the greater occipital nerve. Autopsy study with clinical correlations. Spine. 1991;16:475–8.
Natsis K, Baraliakos X, Appell HJ, Tsikaras P, Gigis I, Koebke J. The course of the greater occipital nerve in the suboccipital region: a proposal for setting landmarks for local anesthesia in patients with occipital neuralgia. Clin Anat. 2006;19:332–6. doi:10.1002/ca.20190.
Hadden S. Neuralgic headache and facial pain. Arch Neurol Psychiatr. 1940;43:405–8.
Skillern PG. Great occipital-trigeminus syndrome as revealed by induction of block. AMA Arch Neurol Psychiatry. 1954;72:335–40.
Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain. 2002;125(Pt 7):1496–509.
Bartsch T, Goadsby PJ. Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain. 2003;126(Pt 8):1801–13. doi:10.1093/brain/awg190.
Busch V, Jakob W, Juergens T, Schulte-Mattler W, Kaube H, May A. Functional connectivity between trigeminal and occipital nerves revealed by occipital nerve blockade and nociceptive blink reflexes. Cephalalgia. 2006;26:50–5. doi:10.1111/j.1468-2982.2005.00992.x.
Busch V, Jakob W, Juergens T, Schulte-Mattler W, Kaube H, May A. Occipital nerve blockade in chronic cluster headache patients and functional connectivity between trigeminal and occipital nerves. Cephalalgia. 2007;27:1206–14. doi:10.1111/j.1468-2982.2007.01424.x.
Rozen TD. Non-hypothalamic cluster headache: the role of the greater occipital nerve in cluster headache pathogenesis. J Headache Pain. 2005;6:149–51. doi:10.1007/s10194-005-0171-4.
Goadsby PJ, Bartsch T, Dodick DW. Occipital nerve stimulation for headache: mechanisms and efficacy. Headache. 2008;48:313–8. doi:10.1111/j.1526-4610.2007.01022.x.
Brewer AC, Trentman TL, Ivancic MG, Vargas BB, Rebecca AM, Zimmerman RS, et al. Long-term outcome in occipital nerve stimulation patients with medically intractable primary headache disorders. Neuromodulation. 2012. doi:10.1111/j.1525-1403.2012.00490.x.
Magis D, Schoenen J. Advances and challenges in neurostimulation for headaches. Lancet Neurol. 2012;11:708–19. doi:10.1016/S1474-4422(12)70139-4.
•• Tobin J, Flitman S. Occipital nerve blocks: when and what to inject? Headache. 2009;49:1521–33. doi:10.1111/j.1526-4610.2009.01493.x. This is an exhaustive review of GON injections for many indications and with a wide array of techniques. Tables provide a useful tool for the clinician.
Levin M. Nerve blocks in the treatment of headache. Neurotherapeutics. 2010;7:197–203. doi:10.1016/j.nurt.2010.03.001.
• Ashkenazi A, Blumenfeld A, Napchan U, Narouze S, Grosberg B, Nett R, et al. Peripheral nerve blocks and trigger point injections in headache management— a systematic review and suggestions for future research. Headache. 2010;50:943–52. doi:10.1111/j.1526-4610.2010.01675.x. A reference article to understand the role of blocks in headache management. It also addresses supra-orbital nerve and lesser occipital nerve blocks.
• Pearce J. Greater occipital nerve block: a diagnostic test? Adv Clin Neurosci Rehabil. 2008;8:15–7. Short but insightful article describing the different GON injections techniques. It also underlines that a positive response to a GON block is to be expected with many headache disorders, not only with occipital neuralgia.
The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24(Suppl 1):9–160.
Goadsby PJ, Cittadini E, Cohen AS. Trigeminal autonomic cephalalgias: paroxysmal hemicrania, SUNCT/SUNA, and hemicrania continua. Semin Neurol. 2010;30:186–91. doi:10.1055/s-0030-1249227.
Leone M, Bussone G. Pathophysiology of trigeminal autonomic cephalalgias. Lancet Neurol. 2009;8:755–64. doi:10.1016/S1474-4422(09)70133-4.
Fuad F, Jones NS. Paroxysmal hemicrania and cluster headache: 2 discrete entities or is there an overlap? Clin Otolaryngol Allied Sci. 2002;27:472–9.
Zidverc-Trajkovic J, Pavlovic AM, Mijajlovic M, Jovanovic Z, Sternic N, Kostic VS. Cluster headache and paroxysmal hemicrania: differential diagnosis. Cephalalgia. 2005;25:244–8. doi:10.1111/j.1468-2982.2004.00838.x.
Donnet A, et al. Chronic cluster headache: a French clinical descriptive study. J Neurol Neurosurg Psychiatry. 2007;78:1354–8.
Ashkenazi A, Schwedt T. Cluster headache—acute and prophylactic therapy. Headache. 2011;51:272–86. doi:10.1111/j.1526-4610.2010.01830.x.
Francis GJ, Becker WJ, Pringsheim TM. Acute and preventive pharmacologic treatment of cluster headache. Neurology. 2010;75:463–73. doi:10.1212/WNL.0b013e3181eb58c8.
Tfelt-Hansen PC, Jensen RH. Management of cluster headache. CNS Drugs. 2012;26:571–80. doi:10.2165/11632850-000000000-00000.
Prakash S, Dholakia SY, Shah KA. A patient with chronic cluster headache responsive to high-dose indomethacin: is there an overlap with chronic paroxysmal hemicrania? Cephalalgia. 2008;28:778–81. doi:10.1111/j.1468-2982.2008.01581.x.
Prakash S, Shah ND, Chavda BV. Cluster headache responsive to indomethacin: case reports and a critical review of the literature. Cephalalgia. 2010;30:975–82. doi:10.1177/0333102409357642.
Prakash S, Golwala P. A proposal for revision of hemicrania continua diagnostic criteria based on critical analysis of 62 patients. Cephalalgia. 2012;32:860–8. doi:10.1177/0333102412452043.
Cittadini E, Goadsby PJ. Update on hemicrania continua. Curr Pain Headache Rep. 2011;15:51–6. doi:10.1007/s11916-010-0156-0.
Robbins MS, Grosberg BM, Lipton RB. Coexisting trigeminal autonomic cephalalgias and hemicrania continua. Headache. 2010;50:489–96. doi:10.1111/j.1526-4610.2009.01610.x.
Marmura MJ, Silberstein SD, Gupta M. Hemicrania continua: who responds to indomethacin? Cephalalgia. 2009;29:300–7. doi:10.1111/j.1468-2982.2008.01719.x.
Prakash S, Husain M, Sureka DS, Shah NP, Shah ND. Is there need to search for alternatives to indomethacin for hemicrania continua? Case reports and a review. J Neurol Sci. 2009;277:187–90. doi:10.1016/j.jns.2008.10.027.
Cohen AS. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing. Cephalalgia. 2007;27:824–32. doi:10.1111/j.1468-2982.2007.01352.x.
Anthony M. Arrest of attacks of cluster headache by local steroid injection of the occipital nerve. In: Clifford Rose F, editor. Migraine: clinical and research advances. Basel: Karger; 1985. p. 168–73.
Anthony M. Cervicogenic headache: prevalence and response to local steroid therapy. Clin Exp Rheumatol. 2000;18(2 Suppl 19):S59–64.
Bigo A, Delrieu F, Bousser MG. Treatment of vascular pain of the face by methylprednisolone injection into the area of the greater occipital nerve: 16 cases. Rev Neurol (Paris). 1989;145:160–2.
Peres MF, Stiles MA, Siow HC, Rozen TD, Young WB, Silberstein SD. Greater occipital nerve blockade for cluster headache. Cephalalgia. 2002;22:520–2.
Afridi SK, Shields KG, Bhola R, Goadsby PJ. Greater occipital nerve injection in primary headache syndromes — prolonged effects from a single injection. Pain. 2006;122:126–9. doi:10.1016/j.pain.2006.01.016.
Gantenbein AR, Lutz NJ, Riederer F, Sandor PS. Efficacy and safety of 121 injections of the greater occipital nerve in episodic and chronic cluster headache. Cephalalgia. 2012;32:630–4. doi:10.1177/0333102412443335.
Ambrosini A, Vandenheede M, Rossi P, Aloj F, Sauli E, Pierelli F, et al. Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain. 2005;118:92–6. doi:10.1016/j.pain.2005.07.015.
•• Leroux E, Valade D, Taifas I, Vicaut E, Chagnon M, Roos C, et al. Suboccipital steroid injections for transitional treatment of patients with more than 2 cluster headache attacks per day: a randomized, double-blind, placebo-controlled trial. Lancet Neurol. 2011;10:891–7. doi:10.1016/S1474-4422(11)70186-7. This randomized-controlled trial showed the effect if suboccipital steroids alone for cluster headache and detailed the benefits of this technique in more objective detail than previous series.
Altim monography (cortivazol). 84th ed. Paris; 2008.
Porta-Etessam J, Cuadrado ML, Galan L, Sampedro A, Valencia C. Temporal response to bupivacaine bilateral great occipital block in a patient with SUNCT syndrome. J Headache Pain. 2010;11:179. doi:10.1007/s10194-010-0204-5.
Antonaci F, Pareja JA, Caminero AB, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua: anesthetic blockades of pericranial nerves. Funct Neurol. 1997;12:11–5.
Guerrero AL, Herrero-Velazquez S, Penas ML, Mulero P, Pedraza MI, Cortijo E, et al. Peripheral nerve blocks: a therapeutic alternative for hemicrania continua. Cephalalgia. 2012;32:505–8. doi:10.1177/0333102412439800.
Ashkenazi A. Allodynia in cluster headache. Curr Pain Headache Rep. 2010;14:140–4. doi:10.1007/s11916-010-0097-7.
Gaul C, Christmann N, Schroder D, Weber R, Shanib H, Diener HC, et al. Differences in clinical characteristics and frequency of accompanying migraine features in episodic and chronic cluster headache. Cephalalgia. 2012;32:571–7. doi:10.1177/0333102412444012.
Loukas M, El-Sedfy A, Tubbs RS, Louis Jr RG, Wartmann CH, Curry B, et al. Identification of greater occipital nerve landmarks for the treatment of occipital neuralgia. Folia Morphol (Warsz). 2006;65:337–42.
Mosser SW, Guyuron B, Janis JE, Rohrich RJ. The anatomy of the greater occipital nerve: implications for the etiology of migraine headaches. Plast Reconstr Surg. 2004;113:693–7. doi:10.1097/01.PRS.0000101502.22727.5D. discussion 8–700.
Eom KS, Kim TY. Greater occipital nerve block by using transcranial Doppler ultrasonography. Pain Physician. 2010;13:395–6.
Greher M, Moriggl B, Curatolo M, Kirchmair L, Eichenberger U. Sonographic visualization and ultrasound-guided blockade of the greater occipital nerve: a comparison of 2 selective techniques confirmed by anatomical dissection. Br J Anaesth. 2010;104:637–42. doi:10.1093/bja/aeq052.
Aubry S, Kastler B, Bier V, Hadjidekov V, Hussein HH, Fergane B. Evaluation of the effectiveness of CT-guided infiltration in the treatment of Arnold’s neuralgia. Neuroradiology. 2009;51:163–8. doi:10.1007/s00234-008-0480-9.
Tetzlaff JE. The pharmacology of local anesthetics. Anesthesiol Clin N Am. 2000;18:217–33. v.
Ashkenazi A, Matro R, Shaw JW, Abbas MA, Silberstein SD. Greater occipital nerve block using local anesthetics alone or with triamcinolone for transformed migraine: a randomized comparative study. J Neurol Neurosurg Psychiatry. 2008;79:415–7. doi:10.1136/jnnp.2007.124420.
Jammes JL. The treatment of cluster headaches with prednisone. Dis Nerv Syst. 1975;36:375–6.
Couch Jr JR, Ziegler DK. Prednisone therapy for cluster headache. Headache. 1978;18:219–21.
Lavin PJ, Workman R. Cushing syndrome induced by serial occipital nerve blocks containing corticosteroids. Headache. 2001;41:902–4.
Younes M, Neffati F, Touzi M, Hassen-Zrour S, Fendri Y, Bejia I, et al. Systemic effects of epidural and intra-articular glucocorticoid injections in diabetic and non-diabetic patients. Joint Bone Spine. 2007;74:472–6. doi:10.1016/j.jbspin.2006.10.009.
Takeda K, Sawamura S, Sekiyama H, Tamai H, Hanaoka K. Effect of methylprednisolone on neuropathic pain and spinal glial activation in rats. Anesthesiology. 2004;100:1249–57.
Johansson A, Bennett GJ. Effect of local methylprednisolone on pain in a nerve injury model. A pilot study. Reg Anesth. 1997;22:59–65.
Johansson A, Hao J, Sjolund B. Local corticosteroid application blocks transmission in normal nociceptive C-fibres. Acta Anaesthesiol Scand. 1990;34:335–8.
Eker HE, Cok OY, Aribogan A, Arslan G. Management of neuropathic pain with methylprednisolone at the site of nerve injury. Pain Med. 2012;13:443–51. doi:10.1111/j.1526-4637.2011.01323.x.
Weibelt S, Andress-Rothrock D, King W, Rothrock J. Suboccipital nerve blocks for suppression of chronic migraine: safety, efficacy, and predictors of outcome. Headache. 2010;50:1041–4. doi:10.1111/j.1526-4610.2010.01687.x.
Shields KG, Levy MJ, Goadsby PJ. Alopecia and cutaneous atrophy after greater occipital nerve infiltration with corticosteroid. Neurology. 2004;63:2193–4.
Mutagi H, Doger A, Kapur S. Full-thickness local soft tissue atrophy following steroid injection to greater occipital nerve. Pain Pract. 2011;11:582–3. doi:10.1111/j.1533-2500.2011.00501.x.
Waterbrook AL, Germann CA, Southall JC. Is epinephrine harmful when used with anesthetics for digital nerve blocks? Ann Emerg Med. 2007;50:472–5.
Caldwell JR. Intra-articular corticosteroids. Guide to selection and indications for use. Drugs. 1996;52:507–14.
Conflict of Interest
Dr. E. Leroux serves as a board member for Pfizer, Merck, Allergan, and Tribute Pharmaceuticals. Dr. Leroux serves as a consultant for Merck and Allergan. Dr. Leroux has received a grant from Allergan. Dr. Leroux has received unrestricted educational grants from Merck, Pfizer, Allergan, and Teva. Dr. Leroux has received payment for lectures from Pfizer, Merck, Johnson and Johnson, Purdue, and Teva.
Dr. Anne Ducros serves as Associated Editor of Cephalalgia. Dr. Ducros has received an academic research grant from CIRC. Dr. Ducros has received payments for lectures from Almirall, Merck Sharpe and Dome, and Pfizer.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Trigeminal Autonomic Cephalalgias
Rights and permissions
About this article
Cite this article
Leroux, E., Ducros, A. Occipital Injections for Trigemino-Autonomic Cephalalgias: Evidence and Uncertainties. Curr Pain Headache Rep 17, 325 (2013). https://doi.org/10.1007/s11916-013-0325-z
Published:
DOI: https://doi.org/10.1007/s11916-013-0325-z